Ordin nr. 1301/500/2008 din 11 iulie 2008 Partea a ii-a

non-opioide

Pentru durere acută la care tratamentul cu aspirină

şi/sau paracetamol este contraindicat sau nu a dat

rezultate.

Se aplică tuturor denumirilor comerciale, formelor farmaceutice şi concentraţiilor corespunzătoare DCI-ului.
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

N02AX02 TRAMADOLUM COMPR. ELIB. MODIF. 100 mg

TRAMADOLOR(R) 100 ID 100 mg HEXAL AG
N02AX02 TRAMADOLUM COMPR. ELIB. PREL. 100 mg

NOAX UNO 100 mg 100 mg LABOPHARM EUROPE LIMITED

TRALGIT SR 100 100 mg ZENTIVA AS

TRAMADOL(R) RETARD 100 mg KRKA D.D.

N02AX02 TRAMADOLUM COMPR. FILM. ELIB. 100 mg

PREL.

TRAMAL RETARD 100 mg 100 mg GRUNENTHAL GMBH
N02AX02 TRAMADOLUM SOL. INJ. 100 mg

MABRON 100 mg MEDOCHEMIE LTD.

TRADOLAN 100 mg LANNACHER HEILMITTEL GMBH
Prescriere limitată: Tratamentul de scurtă durată al durerii acute
N02AX02 TRAMADOLUM SUPOZ. 100 mg

TRADOLAN 100 mg LANNACHER HEILMITTEL GMBH

TRAMADOL 100 mg KRKA D.D.

TRAMAG 100 100 mg MAGISTRA C & C

TRAMAL(R) 100 mg GRUNENTHAL GMBH
N02AX02 TRAMADOLUM SOL. INJ. 100 mg/2 ml

TRALGIT 100 100 mg/2 ml ZENTIVA A.S.

Prescriere limitată: Tratamentul de scurtă durată al durerii acute
N02AX02 TRAMADOLUM PIC. ORALE, SOL. 100 mg/ml

TRALGIT 100 mg/ml ZENTIVA A.S.

N02AX02 TRAMADOLUM SOL. ORALA 100 mg/ml

TRADOLAN 100 mg/ml LANNACHER HEILMITTEL GMBH

N02AX02 TRAMADOLUM COMPR. ELIB. PREL 150 mg

TRALGIT SR 150 150 mg ZENTIVA AS

N02AX02 TRAMADOLUM COMPR. FILM. ELIB. 150 mg

PREL.

TRAMADOL RETARD 150 mg 150 mg KRKA D.D. NOVO MESTO

TRAMAL RETARD 150 mg 150 mg GRUNENTHAL GMBH

N02AX02 TRAMADOLUM COMPR. ELIB. PREL. 200 mg

NOAX UNO 200 mg 200 mg LABOPHARM EUROPE LIMITED

TRALGIT SR 200 200 mg ZENTIVA AS
N02AX02 TRAMADOLUM COMPR. FILM. ELIB. 200 mg

PREL.

TRAMADOL RETARD 200 mg 200 mg KRKA D.D. NOVO MESTO

TRAMAL RETARD 200 mg 200 mg GRUNENTHAL GMBH

N02AX02 TRAMADOLUM COMPR. ELIB. PREL. 300 mg

NOAX UNO 300 mg 300 mg LABOPHARM EUROPE LIMITED

N02AX02 TRAMADOLUM CAPS. 50 mg

K-ALMA(R) 50 mg ANTIBIOTICE SA

MABRON 50 mg 50 mg MEDOCHEMIE LTD.

TRALGIT 50 50 mg ZENTIVA A.S.

TRAMACALM 50 mg AC HELCOR SRL

TRAMADOL 50 mg KRKA D.D.

TRAMADOL LPH 50 mg 50 mg LABORMED PHARMA SA

TRAMADOL AL 50 50 mg ALIUD(R) PHARMA

GMBH & CO. KG

TRAMADOL ARENA 50 mg ARENA GROUP S.A.

TRAMAL(R) 50 mg GRUNENTHAL GMBH

URGENDOL 50 mg MEDICAROM GROUP SRL

N02AX02 TRAMADOLUM COMPR. 50 mg

TRAMADOL 50 mg 50 mg OZONE LABORATORIES LTD.

TRAMADOL EEL 50 mg BIO EEL SRL

TRAMAG 50 50 mg MAGISTRA C & C

N02AX02 TRAMADOLUM COMPR. FILM. 50 mg

TRADOLAN 50 mg 50 mg LANNACHER HEILMITTEL GMBH

N02AX02 TRAMADOLUM SOL. INJ. 50 mg

TRADOLAN 50 mg 50 mg LANNACHER HEILMITTEL GMBH

Prescriere limitată: Tratamentul de scurtă durată al durerii acute
N02AX02 TRAMADOLUM SOL. INJ. 50 mg/ml

TRALGIT 50 50 mg/ml ZENTIVA A.S.

TRAMADOL 50 mg/ml KRKA D.D.

TRAMADOL(R) AL 100 Fiole 50 mg/ml ALIUDR(R) PHARMA

GMBH & CO. KG

TRAMAL(R) 100 50 mg/ml GRUNENTHAL GMBH

TRAMAL(R) 50 50 mg/ml GRUNENTHAL GMBH

URGENDOL 50 mg/ml MEDICAROM GROUP SRL

Prescriere limitată: Tratamentul de scurtă durată al durerii acute
N02AX02 TRAMADOLUM PIC. ORALE, SOL.

TRAMADOL AL PICĂTURI ALIUD PHARMA GMBH & CO. KG

N02AX02 TRAMADOLUM PICATURI ORALE - SOL. 100 mg/ml

TRAMAL(R) 100 mg/ml GRUNENTHAL GMBH

________________________________________________________________________________
______________________________________________________________________________

| 919 |R05CB13| DORNAZA ALFA** | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

R05CB13 DORNAZA ALFA SOL. INHAL 1 mg/ml

PULMOZYME 1 mg/ml ROCHE ROMANIA S.R.L.

________________________________________________________________________________

______________________________________________________________________________

| 920 |V03AC03| DEFERASIROXUM** | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

V03AC03 DEFERASIROXUM COMPR. DISP. 125 mg

EXJADE 125 mg 125 mg NOVARTIS EUROPHARM LTD.
V03AC03 DEFERASIROXUM COMPR. DISP. 250 mg

EXJADE 250 mg 250 mg NOVARTIS EUROPHARM LTD.

V03AC03 DEFERASIROXUM COMPR. DISP. 500 mg

EXJADE 500 mg 500 mg NOVARTIS EUROPHARM LTD.

________________________________________________________________________________
______________________________________________________________________________

| 921 |V03AF01| MESNUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

V03AF01 MESNUM SOL. INJ. 400 mg/4 ml

UROMITEXAN(R) 400 mg 400 mg/4 ml BAXTER ONCOLOGY GMBH

________________________________________________________________________________

SUBLISTA C2 - P9: PROGRAM NAŢIONAL DE TRANSPLANT DE ORGANE, ŢESUTURI ŞI CELULE DE ORIGINE UMANĂ. P9.2: TRANSPLANT DE CORD
______________________________________________________________________________

| 922 |B01AB08| REVIPARINUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

B01AB08 REVIPARINUM SOL. INJ. 1432 ui/0.25 ml

CLIVARIN(R) 1432 UI/0.25 ml 1432 ui/0.25 ml ABBOTT GMBH & CO. KG
B01AB08 REVIPARINUM SOL. INJ. 3436 ui/0.6 ml

CLIVARIN(R) 3436 UI/0,6 ml 3436 ui/0.6 ml ABBOTT GMBH & CO. KG

________________________________________________________________________________
______________________________________________________________________________

| 923 |B05AA06| POLYGELINUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

B05AA06 POLYGELINUM SOL. PERF. 3.5%

HAEMACCEL 3.5% THERASELECT GMBH

________________________________________________________________________________

______________________________________________________________________________

| 924 |C01CA24| EPINEPHRINUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

C01CA24 EPINEPHRINUM SOL. INJ. 1 mg/ml

ADRENALINA 1 mg 1 mg/ml TERAPIA SA

________________________________________________________________________________

______________________________________________________________________________

| 925 |J01CR05| PIPERACILLINUM + TAZOBACTAMUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

J01CR05 PIPERACILLINUM + LIOF. PT. SOL. INJ.

TAZOBACTAMUM

TAZOCIN 2,25 WYETH LEDERLE PHARMA GMBH

TAZOCIN 4,5 WYETH LEDERLE PHARMA GMBH

________________________________________________________________________________

______________________________________________________________________________

| 926 |J01DD12| CEFOPERAZONUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

J01DD12 CEFOPERAZONUM PULB. PT. SOL. INJ. 1 g

LYZONE 1 g 1 g MEDICAROM GROUP S.R.L.

MEDOCEF 1 g 1 g MEDOCHEMIE LTD.

J01DD12 CEFOPERAZONUM PULB. PT. SOL. INJ. 2 g

LYZONE 2 g 2 g MEDICAROM GROUP S.R.L.

MEDOCEF 2 g 2 g MEDOCHEMIE LTD.
J01DD12 CEFOPERAZONUM PULB. PT. SOL. INJ. 500 mg

CEFOZON 500 mg 500 mg E.I.P.I.CO. MED S.R.L.

J01DD12 CEFOPERAZONUM PULB. PT. SOL. 1 g

INJ./PERF. I.M./I.V.

CEFOZON 1 g 1 g E.I.P.I.CO. MED S.R.L.

________________________________________________________________________________

______________________________________________________________________________

| 927 |J01DH51| IMIPENEMUM + CILASTATINUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

J01DH51 IMIPENEMUM + PULB. PT. SOL. PERF.

CILASTATINUM

TIENAM I.V. MERCK SHARP & DOHME

ROMANIA S.R.L.

________________________________________________________________________________

______________________________________________________________________________

| 928 |J01XX08| LINEZOLIDUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

J01XX08 LINEZOLIDUM GRAN. PT. SUSP. ORALA 100 mg/5 ml

ZYVOXID(R) 100 mg/5 ml PFIZER EUROPE MA EEIG
J01XX08 LINEZOLIDUM SOL. PERF. 2 mg/ml

ZYVOXID(R) 2 mg/ml PFIZER EUROPE MA EEIG

J01XX08 LINEZOLIDUM COMPR. FILM. 600 mg

ZYVOXID(R) 600 mg PFIZER EUROPE MA EEIG

________________________________________________________________________________
______________________________________________________________________________

| 929 |J02AC01| FLUCONAZOLUM | |

|_______|_______|____________________________________________|_________________|
Prescriere limitată: Tratament de întreţinere la pacienţi cu meningită